Diabetic Neuropathy Collection: Introduction to Diabetic Neuropathy Uazman Alam Editorial Open access 17 February 2020 Pages: 755 - 760
Diabetic Neuropathy Collection: Progress in Diagnosis and Screening Nikolaos Papanas Editorial Open access 28 February 2020 Pages: 761 - 764
Diabetic Neuropathy Collection: Treatment of Diabetic Neuropathy Uazman Alam Editorial Open access 09 March 2020 Pages: 765 - 772
Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders Amedeo LonardoEnrica Baldelli Commentary Open access 07 March 2020 Pages: 773 - 777
Post-Transplantation Diabetes Mellitus Syed Haris AhmedKathryn BiddleShazli Azmi Review Open access 24 February 2020 Pages: 779 - 801
Social Inequality and Diabetes: A Commentary Katharine D. Barnard-KellyDaniel Cherñavvsky Review Open access 02 March 2020 Pages: 803 - 811
Basic and Clinical Pharmaco-Therapeutics of SGLT2 Inhibitors: A Contemporary Update Sanjay KalraKimi K. ShettyJignesh K. Ved Review Open access 04 March 2020 Pages: 813 - 833
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes Win L. YinSteve C. BainThinzar Min Review Open access 17 March 2020 Pages: 835 - 844
Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes Aleksandra JoticTanja MilicicNebojsa M. Lalic Original Research Open access 15 February 2020 Pages: 845 - 858
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study Jiwoo LeeYou-Cheol HwangJoong-Yeol Park Original Research Open access 17 February 2020 Pages: 859 - 871
Development and Validation of a New Diabetes Risk Score in Guyana Julia LoweCalvin KeBrian Ostrow Original Research Open access 18 February 2020 Pages: 873 - 883
Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22) Xue-Lian ZhangGang WanBeijing Communities Diabetes Study Group Original Research Open access 21 February 2020 Pages: 885 - 903
Association Between Maternal Glucose/Lipid Metabolism Parameters and Abnormal Newborn Birth Weight in Gestational Diabetes Complicated by Preeclampsia: A Retrospective Analysis of 248 Cases Yunshan XiaoXueqin Zhang Original Research Open access 27 February 2020 Pages: 905 - 914
Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring Qing LingJing LuYan Bi Original Research Open access 02 March 2020 Pages: 915 - 925
Effectiveness of the Freestyle Libre Flash Glucose Monitoring System on Diabetes Distress Among Individuals with Type 1 Diabetes: A Prospective Study Ayman A. Al HayekAsirvatham A. RobertMohamed A. Al Dawish Original Research Open access 07 March 2020 Pages: 927 - 937
EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China Yichen ZhangJing WuLizheng Shi Original Research Open access 09 March 2020 Pages: 939 - 950
Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus Masako SaitoAtsunori KaibaraEiji Ueyama Original Research Open access 12 March 2020 Pages: 951 - 964
Risk Factors of Ketosis in Obese Ketosis-Prone Diabetic Patients: A Case-Control Study Li ShiLiang ZhouJin-luo Cheng Original Research Open access 13 March 2020 Pages: 965 - 977
Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus Kalliopi PafiliGrigorios TrypsianisNikolaos Papanas Original Research Open access 14 March 2020 Pages: 979 - 986
A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation Thiyagarajan ThangaveluElizabeth LydenVijay Shivaswamy Brief Report Open access 18 February 2020 Pages: 987 - 994
Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study Xuejun Victor PengRajeev AyyagariVivian Fonseca Brief Report Open access 28 February 2020 Pages: 995 - 1005
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L Lawrence BlondeLori BerardDenis Raccah Brief Report Open access 12 March 2020 Pages: 1007 - 1015
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design Tadej BattelinoZsolt BosnyakRichard Bergenstal Study Protocol Open access 25 February 2020 Pages: 1017 - 1027
Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective Martin HaluzíkMilan FlekačPéter Kempler Practical Approach Open access 06 March 2020 Pages: 1029 - 1043